Aveanna Healthcare Holdings (AVAH) shares have climbed about 1% in recent trading. Over the past three months, the stock has seen a gain of 43%, reflecting a substantial shift in investor sentiment for the company.

See our latest analysis for Aveanna Healthcare Holdings.

Momentum has clearly shifted for Aveanna, with investors fueling a dramatic rebound in recent months. After a tough stretch, the stock’s 94% year-to-date share price return and 50% total return over the past year suggest changing expectations around the business and its growth outlook.

If healthcare turnaround stories spark your interest, discover more potential movers with our curated See the full list for free..

But after such a sharp recovery, is Aveanna Healthcare still trading at a bargain price? Or have recent gains already factored in brighter prospects, leaving little room for further upside for would-be buyers?

With Aveanna Healthcare's fair value set at $9.61 per share according to the most widely followed narrative, the current closing price of $8.75 suggests there could be more upside, pending the company's ability to deliver on growth expectations. Below, a key catalyst is highlighted from the narrative itself.

Ongoing investment in operational efficiencies (such as modernizing digital workflows, centralized billing, and preferred payer alignment) is expected to drive further margin expansion and increase free cash flow, strengthening liquidity and enabling future M&A-led growth.

Read the complete narrative.

Want to know what ambitious growth targets and margin improvements back up this valuation? The real story hinges on transformative efficiency plays and bold earnings projections. Find out which levers analysts think could create outsized returns for Aveanna and what future numbers they are betting on. Ready for the details that are shaping this narrative?

Result: Fair Value of $9.61 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent wage inflation or stricter Medicaid budgets could put pressure on Aveanna’s margins and growth outlook, challenging the optimistic narrative that has supported recent gains.

Find out about the key risks to this Aveanna Healthcare Holdings narrative.

Looking through the lens of the price-to-earnings ratio, Aveanna Healthcare trades at 24.2x, well below its peer group’s 51.2x but above the broader US Healthcare industry average of 21.1x. This mix of relative value and market premium hints at both opportunity and risk if market sentiment shifts. Will Aveanna’s story keep attracting buyers, or is its valuation already full?

See what the numbers say about this price — find out in our valuation breakdown.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Aveanna Healthcare Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 870 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

If you want to take a fresh look at the numbers or bring your own perspective to the table, you can easily build your own narrative in just a few minutes. Do it your way.

A great starting point for your Aveanna Healthcare Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Seize your edge with Simply Wall Street’s powerful tools. Unlock new opportunities and stay ahead of the market by checking out these three unmissable stock screens:

Uncover fresh value plays by tracking these 870 undervalued stocks based on cash flows that are poised to outperform, based on strong underlying fundamentals and attractive cash flow metrics.

Capture future growth by examining these 24 AI penny stocks as they harness artificial intelligence to disrupt industries and accelerate long-term gains.

Tap into breakthrough potential with these 27 quantum computing stocks at the forefront of the next technological wave, offering exposure to pioneering innovation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AVAH.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com